Status:

COMPLETED

The Korean TITRATION Study: Comparison of the Self-titration Methods for Glargine-300

Lead Sponsor:

Seoul National University Hospital

Collaborating Sponsors:

Sanofi

Conditions:

Type 2 Diabetes Mellitus

Eligibility:

All Genders

19+ years

Phase:

NA

Brief Summary

The aim of this study is to demonstrate efficacy and safety of self-titration algorithm with Gla-300 using the INSIGHT algorithm (once daily by 1 unit) and the EDITION algorithm (once weekly by 3 unit...

Detailed Description

The primary objective of this study is to obtain efficacy and safety descriptive data on two different titration algorithms: the INSIGHT titration algorithm (self-titration of 1 unit/day) and the EDIT...

Eligibility Criteria

Inclusion

  • Aged ≥ 19 years
  • Treated for T2D for at least 6 months
  • Uncontrolled T2D
  • Use of SMPG
  • HbA1c \> 7% and ≤ 10% in patients with a basal insulin (Gla-100, Gla-300, neutral protamine Hagedorn (NPH), and detemir) or HbA1c \> 7% and ≤ 11% in insulin naive patients
  • Signed informed consent

Exclusion

  • Type 1 diabetes mellitus
  • Pregnancy or lactation
  • Night-shift worker
  • Unwilling to inject insulin or perform SMPG
  • Treated with insulin other than basal insulin within the previous 3 months
  • Not on stable dose of basal insulin (±20%) in the last 3 months
  • Initiation or change in dose of oral anti-hyperglycemic agents in the last 3 months
  • History of alcohol or drug abuse
  • Active cancer or other significant comorbidities which the investigator would make the patients unsuitable for participating in the study
  • Any clinically significant laboratory finding which the which the investigator would make the patients unsuitable for participating in the study
  • Known drug allergy to insulin
  • Not signed informed consent
  • Incompletion of the study
  • Participating in another clinical trial

Key Trial Info

Start Date :

October 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 14 2020

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT03406663

Start Date

October 1 2017

End Date

July 14 2020

Last Update

October 22 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University Hospital

Seoul, South Korea, 110-744